A Dose Of Disruption: How Compounding Pharmacies Are Challenging Big Pharma On GLP-1 Drugs And Drug Patents

forbes.com/sites/sindhyavalloppillil/2025/07/08/a-dose-of-disruption-how-compounding-pharmacies-are-challenging-big-pharma-on-glp-1-drugs-and-drug-patents

As demand for GLP-1 drugs grows, compounding pharmacies and telehealth startups are challenging Big Pharma’s grip on pricing, patents, and access to care.

This story appeared on forbes.com, 2025-07-08 11:00:17.
The Entire Business World on a Single Page. Free to Use →